Skip to main content
Banka BioLoo Limited logo

Banka BioLoo Limited — Investor Relations & Filings

Ticker · BANKA ISIN · INE862Y01015 LEI · 9845007A5B684495YW41 National Stock Exchange of India Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 462 across all filing types
Latest filing 2026-02-13 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BANKA

About Banka BioLoo Limited

https://www.bankabio.com

Banka BioLoo Limited specializes in providing sustainable sanitation solutions through the implementation of bio-digester technology. The company focuses on the design, manufacturing, and installation of bio-toilets and bio-tanks that utilize anaerobic digestion to treat human waste. This technology, originally developed by the Defence Research and Development Organisation (DRDO), converts waste into water and biogas, ensuring zero-waste discharge and environmental protection. The company serves a diverse range of sectors, including public infrastructure, railways, construction sites, and rural communities. Its service offerings extend to the operation and maintenance of sanitation facilities, as well as large-scale waste management projects. By prioritizing water conservation and hygiene, the company addresses critical sanitation challenges while promoting ecological sustainability.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding the publication of unaudited financial results for the quarter and nine months ended 31 December 2025. It references Regulation 47 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers within 48 hours of the Board meeting. The document includes copies of newspaper advertisements and mentions that the financial results are also available on the company's website. The document itself does not contain the financial results or detailed financial statements but is an announcement about the publication of these results. The length is about 15,000 characters, but the content is primarily an announcement and not the full financial report or detailed analysis. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement about the publication of financial results, not the results themselves or a detailed report like an Interim Report (IR).
2026-02-13 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled as an "Investor Presentation on the financial results for the quarter and nine months ended 31 December 2025" and is addressed to the National Stock Exchange of India. It contains detailed financial highlights for Q3 FY25-26, including standalone and consolidated profit and loss accounts, order book details, business segment overview, and strategic initiatives. The content is structured as a presentation with slides, charts, and business updates. It is not a full annual or quarterly report but a detailed presentation aimed at investors summarizing recent financial performance and business outlook. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Investor Presentation (IP).
2026-02-12 English
Outcome of Board Meeting
Regulatory Filings
2026-02-12 English
Outcome of Board Meeting
Regulatory Filings
2026-02-12 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-04 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a letter from Banka BioLoo Limited to the National Stock Exchange of India informing about a scheduled Board Meeting to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) and mentions the trading window closure related to insider trading regulations. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting where these results will be approved. The document length is short (2418 characters) and it serves as an intimation or notice rather than the actual financial report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement and notification rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2026-02-04 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.